Introduction
The translocation 9;22 found in the karyotypes of chronic myelocytic leukemia (CML) patients is strongly associated with CML as a specific chromosome abnormality. It is regarded as a primary abnormality that plays a fundamental role in initiating the malignant process of CML (1) . Additional chromosome abnormalities superimposed on the translocation 9;22, such as +Ph1[j+22q-, +del(22)(qll), etc.], +8 and/or i(17q) also occur in most patients with CML in blastic crisis. These abnormalities reflect the karyotypic evolution of malignant cells in vivo (2) (3) (4) .
Heim and Mitelman (4) presented a hypothesis of karyotypic evolution in CML patients by analyzing the patterns of additional chromosome abnormalities other than translocation 9;22. The major route of karyotypic evolution by their hypothesis was as follows: + 8, + Ph1, or i(17q) are the main additional changes after a translocation 9;22 occurs; + 19, on the other hand, seems to occur later in karyotypic evolution, most often in combination with both + 8 and + Ph1; i(17q) in combination with + 8 is a quite frequent phenomenon, whereas the combinations 'i(17q) and + 19', '+ Ph' and i(17q)', '+ 8, i(17q), and + 19', and '+ Ph1, i(17q), and + 19' are only seen very rarely. These findings testify to the fact that i(17q) apparently has a restrictive role in the cytogenetic evolution in CML, at least when no extra chromosome 8 is present in the cells. The hypothesis, however, is derived from single-column freq1uencies of combinations of abnormalities, such as '+ Ph and + 8' and '+ 8 and i(17q)', without analysis of associations among additional abnormalities.
In the present study, we analyzed 709 cases of Ph1 positive CML karyotypes with additional abnormalities that were derived from the same database of Mitelman et al. (4) and quantified the relationships among additional abnormalities by means of multivariate analysis of frequency table (log-linear models).
Materials and Methods
The material used in this study consisted of 709 Ph1-positive CML karyotypes with additional abnormalities, which were collected from the Catalog of Chromosome Aberrations in Cancer, second edition (5). Single-column frequencies of the additional abnormalities were analyzed by our previously reported computer program (6) (7) (8) a In a hierarchical model, a higher effect cannot be present unless all lower order effects whose indices are subsets of the higher order effect are also included in the model: e.g. if XABC is stated (nonzero), it means that ,u, XA, XB, XC, XB, XAC, XBC are all present. All effects other than four main ones are described in the left-hand side of the column. Since only hierarchical models are considered in this analysis models are also described by a minimal set of effects in parentheses. Parameter estimates of the cells that correspond to 'presence', 'presence and presence', or 'presence and presence and presence' of one, two, or three abnormalities were shown in Table 4 (Model 113) , and then the parameter estimates of the three-way interactions in the thirdorder full model (Model 113) and the best model (Model 103) were nearly 1. Therefore, the four-way 2 x 2 x 2 x 2 contingency table is considered to be fully explained by the second-order full model (Model 80). Furthermore, the second-order model, which only lacks a two-way term AB (Model 67), is also considered to be a reasonable model.
With regard to the cell of '+ 8, + Ph1, + 19', the observed frequency was quite higher than the expected value by the independent model (Model 1), as shown in pattern 7 in Table 3 . The high frequency of the pattern 138 LOG-LINEAR APPLICATIONS TO CHROMOSOME ABNORMALITIES (Tables 3,4 and Fig. 1 ).
